K Strobel

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi PET-positive fibrous dysplasia--a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital, Zurich, Switzerland
    Skeletal Radiol 36:S24-8. 2007
  2. ncbi Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?
    K Strobel
    Department of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Ann Oncol 18:658-64. 2007
  3. ncbi Small bowel invagination caused by intestinal melanoma metastasis: unsuspected diagnosis by FDG-PET/CT imaging
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 32:213-4. 2007
  4. doi Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 36:919-27. 2009
  5. ncbi Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 34:1366-75. 2007
  6. ncbi FDG PET/CT imaging of a gastric fistula
    Klaus Strobel
    Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
    Clin Nucl Med 32:336-7. 2007
  7. ncbi Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT
    Klaus Strobel
    Department of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland, 8091
    AJR Am J Roentgenol 188:W467-74. 2007
  8. ncbi Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Switzerland
    Nucl Med Commun 28:555-9. 2007
  9. doi The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT
    K Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistr 100, 8091, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 35:2000-8. 2008
  10. ncbi High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistr 100, 8091 Zurich, Switzerland
    Radiology 244:566-74. 2007

Detail Information

Publications50

  1. ncbi PET-positive fibrous dysplasia--a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital, Zurich, Switzerland
    Skeletal Radiol 36:S24-8. 2007
    ..In the presented case, an incidentally detected PET-positive asymptomatic fibrous dysplasia was initially misinterpreted as a metastasis in a patient with intimal sarcoma of the pulmonary artery...
  2. ncbi Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?
    K Strobel
    Department of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Ann Oncol 18:658-64. 2007
    ..The aim of this study was to evaluate the necessity of 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) after end of treatment in lymphoma patients who had an interim FDG-PET/CT...
  3. ncbi Small bowel invagination caused by intestinal melanoma metastasis: unsuspected diagnosis by FDG-PET/CT imaging
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 32:213-4. 2007
  4. doi Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 36:919-27. 2009
    ..The aim of the study was to evaluate (18)F-FDG-PET/CT for the detection of synchronous primaries at initial staging of patients with head and neck squamous cell carcinoma (HNSCC)...
  5. ncbi Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 34:1366-75. 2007
    ..To evaluate the usefulness of PET/CT in melanoma patients with an elevated serum S-100B tumour marker level...
  6. ncbi FDG PET/CT imaging of a gastric fistula
    Klaus Strobel
    Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
    Clin Nucl Med 32:336-7. 2007
  7. ncbi Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT
    Klaus Strobel
    Department of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland, 8091
    AJR Am J Roentgenol 188:W467-74. 2007
    ..The purpose of this study was to evaluate the diagnostic performance of planar 99mTc methylene diphosphonate bone scintigraphy compared with SPECT and SPECT fused with CT in patients with focal bone lesions of the axial skeleton...
  8. ncbi Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Switzerland
    Nucl Med Commun 28:555-9. 2007
    ..We therefore objectively and subjectively compared standard 2-D and fully 3-D reconstructed data for FDG PET/CT on a research PET/CT system...
  9. doi The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT
    K Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistr 100, 8091, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 35:2000-8. 2008
    ..To evaluate the value of a dedicated interpretation of the CT images in the differential diagnosis of benign vs. malignant primary bone lesions with 18 fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT)...
  10. ncbi High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistr 100, 8091 Zurich, Switzerland
    Radiology 244:566-74. 2007
    ....
  11. ncbi Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 32:646-8. 2007
    ..FDG-positron emission tomography/computed tomography after six cycles of chemotherapy showed complete metabolic response...
  12. ncbi S-100B and FDG-PET/CT in therapy response assessment of melanoma patients
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Dermatology 215:192-201. 2007
    ..To compare the value of the tumor marker S-100B protein and fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in patients treated for melanoma metastases...
  13. doi Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    J Nucl Med 49:1408-13. 2008
    ..Our objective was to evaluate the value of combined contrast-enhanced (18)F-FDG PET/CT in assessing the resectability of pancreatic cancer and to compare enhanced PET/CT with the performance of PET alone and unenhanced PET/CT...
  14. doi Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistr 100, 8091, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 35:1786-95. 2008
    ..This study aims to compare the use of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B in chemotherapy response assessment of stage IV melanoma patients...
  15. doi Visualization of pericarditis with fluoro-deoxy-glucose-positron emission tomography/computed tomography
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistr 100, 8091 Zurich, Switzerland
    Eur Heart J 29:1212. 2008
  16. ncbi Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings
    K Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 34:813. 2007
  17. ncbi MIBG-SPECT/CT-angiography with 3-D reconstruction of an extra-adrenal phaeochromocytoma with dissection of an aortic aneurysm
    Klaus Strobel
    Division of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 34:150. 2007
  18. doi Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma
    K Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, 8091 Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 36:1774-82. 2009
    ..The objective of this study was to evaluate the value of (18)F-FDG PET/CT and S-100B tumour marker for the detection of liver metastases from uveal melanoma in comparison to liver metastases from cutaneous melanoma...
  19. ncbi Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 31:624-6. 2006
  20. ncbi Changing PET/CT manifestation of neurolymphomatosis
    Klaus Strobel
    Division of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 33:1244. 2006
  21. ncbi PET/CT of a brodie abscess
    Klaus Strobel
    Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
    Clin Nucl Med 31:210. 2006
    ..A Brodie abscess was considered a possible diagnosis. Multifocality could be excluded. CT-guided transosseous biopsy and curettage was performed and the diagnosis of a Brodie abscess was confirmed...
  22. ncbi Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein
    Mirjam Beyeler
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Dermatology 213:187-91. 2006
    ..Early detection of melanoma recurrence is essential for the patient's prognosis. The serum S100 level may be a useful tool to detect relapse early...
  23. ncbi Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB
    B Schwegler
    Clinic for Endocrinology and Diabetes, University Hospital, Zurich, Switzerland
    J Intern Med 263:99-106. 2008
    ..Prevalence, optimal diagnostic approach and consequences of clinically unsuspected osteomyelitis in diabetic foot ulcers are unclear. Early diagnosis of this infection may be crucial to ensure correct management...
  24. doi The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas
    Thomas Schrepfer
    Department of Otorhinolaryngology Head and Neck Surgery, University Hospital Zurich, Switzerland
    Laryngoscope 120:937-44. 2010
    ..Additionally, the clinical significance of the semiquantitative analysis of the standardized uptake value (SUV), its predictive role in the follow-up setting, and its value in detection of synchronous primaries were studied...
  25. doi Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging
    Esther I Schwarz
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 34:249-50. 2009
    ..PET-CT findings, together with medical history, raised the suspicion for a metastasizing ovarian cancer. However, histologic examination demonstrated benign findings, namely abdominal wall leiomyoma and an ovarian follicular cyst...
  26. doi Is there an additional value of SPECT/CT over planar lymphoscintigraphy for sentinel node mapping in oral/oropharyngeal squamous cell carcinoma?
    Stephan K Haerle
    Department of Otolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland
    Ann Surg Oncol 16:3118-24. 2009
    ..The aim was to assess whether there is an additional value of SPECT/CT over LS alone for lymphatic mapping of SLNs in oral/oropharyngeal SCC...
  27. doi The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma
    S K Haerle
    Department of Otolaryngology Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091 Zurich, Switzerland
    Eur Arch Otorhinolaryngol 269:127-33. 2012
    ..In summary, if available, (18)F-FDG-PET/CT is a valuable imaging modality for staging and re-staging sinonasal malignant melanoma to evaluate expansion of the primary tumor, locoregional disease, and distant metastases...
  28. ncbi 18F FDG-PET imaging in musculoskeletal infection
    K D M Stumpe
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital, Zurich, Switzerland
    Q J Nucl Med Mol Imaging 50:131-42. 2006
    ..This article reviews the currently available literature on FDG-PET and PET/CT in the diagnosis of musculoskeletal infection...
  29. doi Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine
    Jan D Soyka
    Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
    J Nucl Med 51:507-10. 2010
    ..Our objective was to investigate the use of bowel preparation before (18)F-FDG PET/CT to reduce intestinal (18)F-FDG uptake...
  30. doi (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma
    Stephan K Haerle
    Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland
    Head Neck 32:319-25. 2010
    ....
  31. doi Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases
    Stephan K Haerle
    Department of Otolaryngology, Head and Neck Surgery, University Hospital Zurich, CH 8091 Zurich, Switzerland
    Head Neck 33:324-9. 2011
    ....
  32. doi Therapeutic impact of [(18)F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain
    Dorothee Rita Fischer
    Department of Nuclear Medicine, University Hospital of Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
    Skeletal Radiol 39:987-97. 2010
    ..To evaluate the therapeutic impact of [(18)F]fluoride positron-emission tomography/computed tomography ([(18)F]fluoride PET/CT) imaging on patients with unclear foot pain...
  33. doi Osteomyelitis and arthritis
    Katrin D M Stumpe
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital, Zurich, Switzerland
    Semin Nucl Med 39:27-35. 2009
    ....
  34. doi Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
    Jan D Soyka
    Department of Nuclear Medicine, University Hospital Zuerich, Zurich, Switzerland
    J Nucl Med 49:354-61. 2008
    ..The aim of this study was to investigate the value of contrast-enhanced PET/CT (cePET/CT) as a first-line restaging tool with a special focus on the importance of the use of intravenous contrast...
  35. ncbi Bone involvement in patients with lymphoma: the role of FDG-PET/CT
    Niklaus G Schaefer
    Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 34:60-7. 2007
    ..To evaluate the diagnostic impact and clinical significance of FDG-avid bone lesions detected by FDG-PET/CT in patients with lymphoma...
  36. ncbi Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Niklaus G Schaefer
    Division of Nuclear Medicine, Department of Radiology, University Hospital Zurich, Zurich, Switzerland
    Radiology 244:257-62. 2007
    ....
  37. ncbi FDG-negative signet ring cell cancer of the stomach with FDG-positive skin metastases
    Ujval Bhure
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 32:226-8. 2007
  38. pmc Assessment of successful incorporation of cages after cervical or lumbar intercorporal fusion with [(18)F]fluoride positron-emission tomography/computed tomography
    Dorothee R Fischer
    Department of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    Eur Spine J 20:640-8. 2011
    ....
  39. ncbi The value of FDG-PET in patients with painful total knee arthroplasty
    Katrin D M Stumpe
    Department of Medical Radiology, Division of Nuclear Medicine, University Hospital, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 33:1218-25. 2006
    ..The purpose of this study was to evaluate 18F-fluorodeoxyglucose (FDG) uptake in patients with painful total knee arthroplasty and to relate FDG uptake to the location of soft tissue pain...
  40. ncbi Cholestasis from malignant melanoma
    Matthias Bramkamp
    Department of Visceral and Transplantation Surgery, University Hospital, Zurich, Switzerland
    J Clin Oncol 25:725-6. 2007
  41. ncbi PET/CT in musculoskeletal infection
    Klaus Strobel
    Department of Medical Radiology, Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
    Semin Musculoskelet Radiol 11:353-64. 2007
    ..This article reviews the currently available literature and addresses the use of FDG-PET/CT in the diagnosis of musculoskeletal infections...
  42. doi FDG uptake in a rheumatoid nodule with imaging appearance similar to a malignant soft tissue tumor
    Klaus Strobel
    Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
    Clin Nucl Med 34:691-2. 2009
    ..She had rheumatoid arthritis for several years. PET/CT showed moderate FDG uptake (SUV max. 4.2) in the known soft tissue lesion. The tumor was resected and histology revealed rheumatoid granulomas with bursitis...
  43. ncbi Comparison of 64-slice CT with gated SPECT for evaluation of left ventricular function
    Tiziano Schepis
    Clinic of Nuclear Medicine, Nuclear Cardiology, University Hospital Zurich, Zurich, Switzerland
    J Nucl Med 47:1288-94. 2006
    ..We aimed at comparing LV dimensions, muscle mass, and function obtained by electrocardiographically gated 64-slice CT versus gated-SPECT...
  44. ncbi Cervical nerve root blocks: indications and role of MR imaging
    Klaus Strobel
    Department of Radiology, Orthopedic University Hospital, Zurich, Switzerland
    Radiology 233:87-92. 2004
    ....
  45. doi 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis
    Klaus Strobel
    Department of Medical Radiology, Division of Nuclear Medicine, University Hospital, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 37:1760-5. 2010
    ..The aim of this study was to evaluate the performance of (18)F-fluoride-PET/CT (PET/CT) for the diagnosis of sacroiliac joint (SIJ) arthritis in patients with active ankylosing spondylitis (AS)...
  46. ncbi Suspected rotator cuff lesions: tissue harmonic imaging versus conventional US of the shoulder
    Klaus Strobel
    Departments of Radiology and Orthopedic Surgery, Orthopedic University Hospital Balgrist, Zurich, Switzerland
    Radiology 230:243-9. 2004
    ..To compare tissue harmonic imaging (THI) of the shoulder with conventional ultrasonography (US) in patients suspected of having rotator cuff lesions...
  47. ncbi Fatty atrophy of supraspinatus and infraspinatus muscles: accuracy of US
    Klaus Strobel
    Department of Radiology, Orthopedic University Hospital, Balgrist, Zurich, Switzerland
    Radiology 237:584-9. 2005
    ..To prospectively evaluate the accuracy of ultrasonography (US) in depicting fatty atrophy of the supraspinatus (SSP) and infraspinatus (ISP) muscles, with magnetic resonance (MR) imaging as the reference standard...
  48. ncbi Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case
    Florian M Buck
    Department of Radiology and Nuclear Medicine, Cantonal Hospital Lucerne, Lucerne, Switzerland
    J Magn Reson Imaging 26:422-6. 2007
    ..Diagnosis was based upon laboratory tests, bone scintigraphy, and MRI findings and was proved by open bone biopsy...
  49. ncbi Posterior entrapment of the long biceps tendon after traumatic shoulder dislocation: findings on MR imaging
    Klaus Strobel
    Kantonsspital Luzern, Röntgeninstitut, 6000 Luzern 16, Switzerland
    AJR Am J Roentgenol 178:238-9. 2002
  50. ncbi MRI features of the acromioclavicular joint that predict pain relief from intraarticular injection
    Klaus Strobel
    Department of Radiology, Orthopedic University Hospital, Balgrist, Forchstr 340, Zurich CH 8008, Switzerland
    AJR Am J Roentgenol 181:755-60. 2003
    ..Our objective was to evaluate the predictive value of various MRI findings in the acromioclavicular joint for pain relief after intraarticular injection...